SP1 and leukemia: In particular, the top 3 transcriptional regulation networks showed SP1, c-Myc and HNF4-alpha as central hubs, suggesting that they might play a role in the pathophysiology of BCR-ABL-positive leukemias and/or represent therapeutic targets.